NO152049C - Analogifremgangsmaate for fremstilling av den farmasoeytisk anvendelige forbindelse 4,5,6,7-tetrahydroisoksazolo (5,4-c)pyridin-3-ol - Google Patents
Analogifremgangsmaate for fremstilling av den farmasoeytisk anvendelige forbindelse 4,5,6,7-tetrahydroisoksazolo (5,4-c)pyridin-3-olInfo
- Publication number
- NO152049C NO152049C NO782127A NO782127A NO152049C NO 152049 C NO152049 C NO 152049C NO 782127 A NO782127 A NO 782127A NO 782127 A NO782127 A NO 782127A NO 152049 C NO152049 C NO 152049C
- Authority
- NO
- Norway
- Prior art keywords
- tetrahydroisocsazolo
- pyridin
- preparing
- pharmaceutical use
- use compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2574077 | 1977-06-20 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO782127L NO782127L (no) | 1978-12-21 |
NO152049B NO152049B (no) | 1985-04-15 |
NO152049C true NO152049C (no) | 1985-07-24 |
Family
ID=10232513
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO782128A NO782128L (no) | 1977-06-20 | 1978-06-19 | Fremgangsmaate for fremstilling av fysiologisk aktive isonikotinsyrederivater |
NO782127A NO152049C (no) | 1977-06-20 | 1978-06-19 | Analogifremgangsmaate for fremstilling av den farmasoeytisk anvendelige forbindelse 4,5,6,7-tetrahydroisoksazolo (5,4-c)pyridin-3-ol |
NO792839A NO792839L (no) | 1977-06-20 | 1979-09-03 | Mellomprodukt for anvendelse ved fremstilling av fysiologisk aktive isonikotinsyrederivater |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO782128A NO782128L (no) | 1977-06-20 | 1978-06-19 | Fremgangsmaate for fremstilling av fysiologisk aktive isonikotinsyrederivater |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO792839A NO792839L (no) | 1977-06-20 | 1979-09-03 | Mellomprodukt for anvendelse ved fremstilling av fysiologisk aktive isonikotinsyrederivater |
Country Status (14)
Country | Link |
---|---|
US (2) | US4278676A (no) |
EP (4) | EP0028017A1 (no) |
JP (2) | JPS5436290A (no) |
AT (1) | AT368505B (no) |
AU (2) | AU3724478A (no) |
CA (1) | CA1107736A (no) |
DK (2) | DK270378A (no) |
ES (2) | ES470912A1 (no) |
FI (2) | FI64376C (no) |
IE (1) | IE47200B1 (no) |
IT (2) | IT1159739B (no) |
NO (3) | NO782128L (no) |
NZ (1) | NZ187615A (no) |
ZA (2) | ZA783492B (no) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3145474A1 (de) * | 1980-11-27 | 1982-09-02 | Kefalas A/S, Koebenhavn-Valby | 3-substituierte 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridinverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
DE3145473A1 (de) * | 1980-11-27 | 1982-08-26 | Kefalas A/S, Koebenhavn-Valby | 2-substituierte 4,5,6,7-tetrahydroisoxazolo (5,4-c) pyridin-3-on-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
EP0083378A1 (en) * | 1981-12-22 | 1983-07-13 | Chugai Seiyaku Kabushiki Kaisha | Tetrahydronicotinamide derivatives, a process for producing the same and a pharmaceutical composition comprising the same |
GB8314391D0 (en) * | 1983-05-24 | 1983-06-29 | Kefalas As | Heterocyclic compounds |
IT1228426B (it) * | 1987-07-20 | 1991-06-17 | Ausimont Spa | Perossiacidi eterociclici |
US4859666A (en) * | 1988-07-06 | 1989-08-22 | Bristol-Myers Company | THAZ derivatives for enhancement of cerebral function |
CN1043051C (zh) * | 1994-07-22 | 1999-04-21 | 国际壳牌研究有限公司 | 制备氢化石蜡的方法 |
WO2004112786A2 (en) | 2003-06-25 | 2004-12-29 | H. Lundbeck A/S | Gaboxadol for treating depression and other affective disorders |
US20050234093A1 (en) * | 2003-06-25 | 2005-10-20 | H. Lundbeck A/S | Treatment of depression and other affective disorders |
AR045540A1 (es) | 2003-09-05 | 2005-11-02 | Lundbeck & Co As H | Metodo de elaboracion de 4,5,6,7 tetrahidroisoxazol [5,4-c] piridin-3-ol (thip) |
US20050176680A1 (en) * | 2003-12-11 | 2005-08-11 | Sepracor, Inc. | Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
US20050137222A1 (en) * | 2003-12-18 | 2005-06-23 | H. Lundbeck A/S | Treatment of insomnia in human patients |
WO2005063248A1 (en) * | 2003-12-22 | 2005-07-14 | Sepracor Inc. | Modafinil combination therapy for improving sleep quality |
WO2005063297A2 (en) * | 2003-12-24 | 2005-07-14 | Sepracor Inc. | Melatonin combination therapy for improving sleep quality |
GB0402118D0 (en) * | 2004-01-30 | 2004-03-03 | Merck Sharp & Dohme | Polymorphic forms of a GABAA agonist |
DE602005018763D1 (de) * | 2004-02-18 | 2010-02-25 | Sepracor Inc | Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität |
GB0417558D0 (en) * | 2004-08-06 | 2004-09-08 | Merck Sharp & Dohme | Novel combination therapy |
EP2292222A1 (en) | 2005-01-28 | 2011-03-09 | H. Lundbeck A/S | Polymorphic Forms of a GABAA Agonist |
US20080262029A1 (en) * | 2005-04-29 | 2008-10-23 | H. Lundbeck A/S | Acid and Base Salt Forms of Gaboxadol |
EP1928437A2 (en) | 2005-08-26 | 2008-06-11 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
US7985756B2 (en) | 2005-10-21 | 2011-07-26 | Braincells Inc. | Modulation of neurogenesis by PDE inhibition |
AU2006308889A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | GABA receptor mediated modulation of neurogenesis |
US20070203216A1 (en) * | 2006-02-14 | 2007-08-30 | Bjarke Ebert | Method of treating inflammatory diseases |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
EP2026813A2 (en) | 2006-05-09 | 2009-02-25 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
WO2007134136A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
KR20090064418A (ko) | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
US20100193652A1 (en) * | 2009-02-02 | 2010-08-05 | William Stajos | Wall Display System And Method Of Providing The Same |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
US8784835B2 (en) * | 2012-07-02 | 2014-07-22 | Trent Austin | Method for producing muscimol and/or reducing ibotenic acid from amanita tissue |
CN104974175A (zh) * | 2014-04-11 | 2015-10-14 | 天津药物研究院 | 一种氨甲基羟异恶唑类似物的制备方法 |
HUE055400T2 (hu) | 2014-06-06 | 2021-11-29 | Ovid Therapeutics Inc | Módszerek a tónusos gátlás növelésére és az Angelman-szindróma kezelésére |
SI3274331T1 (sl) * | 2015-03-24 | 2020-08-31 | H. Lundbeck A/S | Izdelava 4,5,6,7-tetrahidroizozaksolo (5,4-C)piridin-3-ol |
US9682069B2 (en) | 2015-07-17 | 2017-06-20 | Ovid Therapeutics Inc | Methods of treating Dravet syndrome |
IL305342A (en) * | 2015-07-17 | 2023-10-01 | Ovid Therapeutics Inc | Methods for treating developmental disorders with gaboxadol |
US9399034B1 (en) | 2015-08-11 | 2016-07-26 | Ovid Therapeutics Inc | Methods of sedation during critical care treatment |
EP3481387A4 (en) | 2016-08-11 | 2020-04-08 | Ovid Therapeutics Inc | METHOD AND COMPOSITIONS FOR TREATING EPILEPTIC DISEASES |
US10071083B2 (en) | 2017-02-03 | 2018-09-11 | Ovid Therapeutics Inc | Use of gaboxadol in the treatment of tinnitus |
US20180338959A1 (en) | 2017-05-24 | 2018-11-29 | Ovid Therapeutics Inc. | Treatment of depressive disorders |
CN111201022A (zh) | 2017-08-04 | 2020-05-26 | 奥维德医疗公司 | 加波沙朵在治疗糖尿病及相关状况中的用途 |
WO2020061410A1 (en) | 2018-09-20 | 2020-03-26 | Ovid Therapeutics Inc. | Use of gaboxadol for the treatment of tourette syndrome, tics and stuttering |
SG11202105358RA (en) | 2018-11-21 | 2021-06-29 | Certego Therapeutics | Gaboxadol for reducing risk of suicide and rapid relief of depression |
WO2020131856A1 (en) | 2018-12-17 | 2020-06-25 | Ovid Therapeutics Inc. | Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder |
CA3182508A1 (en) | 2020-05-20 | 2021-11-25 | Certego Therapeutics Inc. | Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders |
CN114292224B (zh) * | 2022-03-07 | 2022-05-20 | 中国农业科学院农产品加工研究所 | 一种大麻二酚-2-(n-乙酰基)哌啶酸酯及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2784190A (en) * | 1952-03-28 | 1957-03-05 | Upjohn Co | Alkyl piperidinepropionates |
CA762455A (en) * | 1962-03-22 | 1967-07-04 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Pyrido-pyrimidines |
US3381016A (en) * | 1966-03-04 | 1968-04-30 | Upjohn Co | Isoxazolo[5, 4-b]pyridine derivatives and a method for their preparation |
DE2221770A1 (de) * | 1972-05-04 | 1973-11-15 | Bayer Ag | Verfahren zur herstellung von tetrahydropyridinen |
DK62791A (da) * | 1991-04-09 | 1992-11-09 | Tulip Int As | Fremgangsmaade til saltning af koed samt anlaeg til brug ved udoevelse af fremgangsmaaden |
-
1978
- 1978-06-15 DK DK270378A patent/DK270378A/da unknown
- 1978-06-15 DK DK270278A patent/DK270278A/da unknown
- 1978-06-19 AU AU37244/78A patent/AU3724478A/en active Pending
- 1978-06-19 NO NO782128A patent/NO782128L/no unknown
- 1978-06-19 IE IE1234/78A patent/IE47200B1/en unknown
- 1978-06-19 FI FI781954A patent/FI64376C/fi not_active IP Right Cessation
- 1978-06-19 ES ES470912A patent/ES470912A1/es not_active Expired
- 1978-06-19 ZA ZA00783492A patent/ZA783492B/xx unknown
- 1978-06-19 EP EP80106498A patent/EP0028017A1/en not_active Withdrawn
- 1978-06-19 NO NO782127A patent/NO152049C/no unknown
- 1978-06-19 ZA ZA00783493A patent/ZA783493B/xx unknown
- 1978-06-19 EP EP78100191A patent/EP0000338B1/en not_active Expired
- 1978-06-19 EP EP80106497A patent/EP0027279A1/en not_active Withdrawn
- 1978-06-19 FI FI781955A patent/FI781955A/fi not_active Application Discontinuation
- 1978-06-19 US US05/917,118 patent/US4278676A/en not_active Expired - Lifetime
- 1978-06-19 NZ NZ187615A patent/NZ187615A/xx unknown
- 1978-06-19 ES ES470913A patent/ES470913A1/es not_active Expired
- 1978-06-19 EP EP78100190A patent/EP0000167A1/en not_active Withdrawn
- 1978-06-20 AU AU37298/78A patent/AU521040B2/en not_active Expired
- 1978-06-20 JP JP7480078A patent/JPS5436290A/ja active Pending
- 1978-06-20 JP JP7479978A patent/JPS5436275A/ja active Pending
- 1978-06-20 CA CA305,798A patent/CA1107736A/en not_active Expired
- 1978-06-20 IT IT68450/78A patent/IT1159739B/it active
- 1978-06-20 IT IT7868449A patent/IT7868449A0/it unknown
- 1978-06-20 AT AT0448678A patent/AT368505B/de not_active IP Right Cessation
-
1979
- 1979-09-03 NO NO792839A patent/NO792839L/no unknown
- 1979-12-17 US US06/104,080 patent/US4301287A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FI64376C (fi) | 1983-11-10 |
IT7868449A0 (it) | 1978-06-20 |
NO792839L (no) | 1978-12-21 |
EP0028017A1 (en) | 1981-05-06 |
AU521040B2 (en) | 1982-03-11 |
JPS5436275A (en) | 1979-03-16 |
CA1107736A (en) | 1981-08-25 |
EP0000338B1 (en) | 1981-11-25 |
ZA783493B (en) | 1979-06-27 |
US4278676A (en) | 1981-07-14 |
ES470913A1 (es) | 1979-02-01 |
EP0000338A3 (en) | 1979-06-27 |
IE47200B1 (en) | 1984-01-11 |
DK270378A (da) | 1978-12-21 |
EP0000338A2 (en) | 1979-01-24 |
AU3729878A (en) | 1980-01-03 |
FI781954A (fi) | 1978-12-21 |
DK270278A (da) | 1978-12-21 |
IT7868450A0 (it) | 1978-06-20 |
ATA448678A (de) | 1982-02-15 |
IT1159739B (it) | 1987-03-04 |
NO152049B (no) | 1985-04-15 |
FI781955A (fi) | 1978-12-21 |
US4301287A (en) | 1981-11-17 |
AT368505B (de) | 1982-10-25 |
IE781234L (en) | 1978-12-20 |
JPS5436290A (en) | 1979-03-16 |
EP0027279A1 (en) | 1981-04-22 |
NZ187615A (en) | 1981-12-15 |
ZA783492B (en) | 1979-06-27 |
NO782128L (no) | 1978-12-21 |
AU3724478A (en) | 1980-01-03 |
EP0000167A1 (en) | 1979-01-10 |
FI64376B (fi) | 1983-07-29 |
ES470912A1 (es) | 1979-02-01 |
NO782127L (no) | 1978-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO152049C (no) | Analogifremgangsmaate for fremstilling av den farmasoeytisk anvendelige forbindelse 4,5,6,7-tetrahydroisoksazolo (5,4-c)pyridin-3-ol | |
NO154918C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. | |
IT7849473A0 (it) | Procedimento per preparare 1,2 polibutadiene | |
AR224095A1 (es) | Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3 | |
RO75777A (ro) | Procedeu pentru prepararea unor 1,2-benzizotiazolin-3-one | |
SE7808059L (sv) | Forfarande for framstellning av 1,2,4-triazin-5-on-derivat | |
SE7604475L (sv) | Forfarande for framstellning av 1,1,1-triaryl-alkylaminer | |
RO82507A (ro) | Procedeu pentru prepararea unor derivati ai acidului 1,2,3-tiadiazol-procedeu pentru prepararea unor derivati ai acidului 1,2,3-tiadiazol-5-carboxilic | |
RO77485A (ro) | Procedeu pentru prepararea 1,2,3-tiadiazol-3-in-5-ilidenureelor | |
RO76721A (ro) | Procedeu pentru prepararea 3.12.-hidroxi-4-fenil-cicloalcanonei | |
AR218498A1 (es) | Procedimiento de preparacion de derivados de 1,3-difenoxipropan-2-ona | |
NO152645C (no) | Fremgangsmaate for fremstilling av klordioksyd. | |
SE7804878L (sv) | Forfarande for framstellning av 1,2-dikloretan | |
ES495819A0 (es) | Procedimiento de preparar derivados 1,2,4-oxadiazolin-5-oni-cos | |
AR224501A1 (es) | Procedimiento de preparacion de derivados de la tieno-(3,2-c)-piridina | |
NO147601C (no) | Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse l-pyroglutamyl-l-histidyl-glycin | |
SE428922B (sv) | Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner | |
SE7802669L (sv) | Forfarande for framstellning av 2,1,3-tiadiazin-4-on-2,2-dioxidderivat | |
IT1094983B (it) | Procedimento per la preparazione di 3,5 di alogeno-aniline | |
ES494286A0 (es) | Procedimiento de preparacion de nuevos derivados 1,1,2-tri- fenilpropanos y -propenos | |
ES491153A0 (es) | Procedimiento de preparar derivados pirrolo(1,2-a)pirimidi- nicos | |
NO145135C (no) | Analogifremgangsmaate ved fremstilling av den terapeutisk aktive forbindelse 3-cyan-n-(n,n-diemtylaminopropyl)-iminodibenzyl | |
NO144067C (no) | Fremgangsmaate for fremstilling av di-n-propylacetonitril. | |
SE7608453L (sv) | Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner | |
RO85268A (ro) | Procedeu pentru prepararea unor derivati de 1,2,4-oxadiazina |